345 related articles for article (PubMed ID: 11950998)
21. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
22. [Trichothiodystrophy: progresssive manifestations].
Foulc P; Jumbou O; David A; Sarasin A; Stalder JF
Ann Dermatol Venereol; 1999 Oct; 126(10):703-7. PubMed ID: 10604009
[TBL] [Abstract][Full Text] [Related]
23. p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.
Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; Gielis S; Vermeulen JP; Wester PW; Vos JG; de Vries A; van Steeg H
Cancer Res; 2004 Aug; 64(15):5118-26. PubMed ID: 15289314
[TBL] [Abstract][Full Text] [Related]
24. Lethality in yeast of trichothiodystrophy (TTD) mutations in the human xeroderma pigmentosum group D gene. Implications for transcriptional defect in TTD.
Guzder SN; Sung P; Prakash S; Prakash L
J Biol Chem; 1995 Jul; 270(30):17660-3. PubMed ID: 7629061
[TBL] [Abstract][Full Text] [Related]
25. Accelerated bone aging in the trichothiodystrophy mouse model.
Diderich KE; Hoeijmakers JH; van Leeuwen JP
J Gerontol A Biol Sci Med Sci; 2003 Nov; 58(11):969. PubMed ID: 14630875
[No Abstract] [Full Text] [Related]
26. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
[TBL] [Abstract][Full Text] [Related]
27. Mutations in XPD helicase prevent its interaction and regulation by p44, another subunit of TFIIH, resulting in Xeroderma pigmentosum (XP) and trichothiodystrophy (TTD) phenotypes.
Coin F; Marinoni JC; Egly JM
Pathol Biol (Paris); 1998 Nov; 46(9):679-80. PubMed ID: 9885814
[No Abstract] [Full Text] [Related]
28. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
[TBL] [Abstract][Full Text] [Related]
29. Repair characteristics and differentiation propensity of long-term cultures of epidermal keratinocytes derived from normal and NER-deficient mice.
Backendorf C; de Wit J; van Oosten M; Stout GJ; Mitchell JR; Borgstein AM; van der Horst GT; de Gruijl FR; Brouwer J; Mullenders LH; Hoeijmakers JH
DNA Repair (Amst); 2005 Nov; 4(11):1325-36. PubMed ID: 16182615
[TBL] [Abstract][Full Text] [Related]
30. Relationship between UV-induced mutant p53 patches and skin tumours, analysed by mutation spectra and by induction kinetics in various DNA-repair-deficient mice.
Rebel H; Kram N; Westerman A; Banus S; van Kranen HJ; de Gruijl FR
Carcinogenesis; 2005 Dec; 26(12):2123-30. PubMed ID: 16051635
[TBL] [Abstract][Full Text] [Related]
31. An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria.
Andressoo JO; Mitchell JR; de Wit J; Hoogstraten D; Volker M; Toussaint W; Speksnijder E; Beems RB; van Steeg H; Jans J; de Zeeuw CI; Jaspers NG; Raams A; Lehmann AR; Vermeulen W; Hoeijmakers JH; van der Horst GT
Cancer Cell; 2006 Aug; 10(2):121-32. PubMed ID: 16904611
[TBL] [Abstract][Full Text] [Related]
32. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.
Aloyz R; Xu ZY; Bello V; Bergeron J; Han FY; Yan Y; Malapetsa A; Alaoui-Jamali MA; Duncan AM; Panasci L
Cancer Res; 2002 Oct; 62(19):5457-62. PubMed ID: 12359753
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype relationships in trichothiodystrophy patients with novel splicing mutations in the XPD gene.
Botta E; Nardo T; Orioli D; Guglielmino R; Ricotti R; Bondanza S; Benedicenti F; Zambruno G; Stefanini M
Hum Mutat; 2009 Mar; 30(3):438-45. PubMed ID: 19085937
[TBL] [Abstract][Full Text] [Related]
34. Defects in the DNA repair and transcription gene ERCC2(XPD) in trichothiodystrophy.
Takayama K; Salazar EP; Broughton BC; Lehmann AR; Sarasin A; Thompson LH; Weber CA
Am J Hum Genet; 1996 Feb; 58(2):263-70. PubMed ID: 8571952
[TBL] [Abstract][Full Text] [Related]
35. Severe growth retardation and short life span of double-mutant mice lacking Xpa and exon 15 of Xpg.
Shiomi N; Mori M; Kito S; Harada YN; Tanaka K; Shiomi T
DNA Repair (Amst); 2005 Mar; 4(3):351-7. PubMed ID: 15661658
[TBL] [Abstract][Full Text] [Related]
36. Tissue specific mutagenic and carcinogenic responses in NER defective mouse models.
Wijnhoven SW; Hoogervorst EM; de Waard H; van der Horst GT; van Steeg H
Mutat Res; 2007 Jan; 614(1-2):77-94. PubMed ID: 16769089
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations.
Compe E; Drané P; Laurent C; Diderich K; Braun C; Hoeijmakers JH; Egly JM
Mol Cell Biol; 2005 Jul; 25(14):6065-76. PubMed ID: 15988019
[TBL] [Abstract][Full Text] [Related]
38. Trichothiodystrophy, a transcription syndrome.
Bergmann E; Egly JM
Trends Genet; 2001 May; 17(5):279-86. PubMed ID: 11335038
[TBL] [Abstract][Full Text] [Related]
39. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer.
Vogel U; Overvad K; Wallin H; Tjønneland A; Nexø BA; Raaschou-Nielsen O
Cancer Lett; 2005 May; 222(1):67-74. PubMed ID: 15837542
[TBL] [Abstract][Full Text] [Related]
40. [XPD (ERCC2) (Xeroderma pigmentosum, group D). Reparation gene].
Bull Cancer; 1998 Dec; 85(12):987-8. PubMed ID: 9988553
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
